Trial Profile
A Randomised, Double Blind, Placebo Controlled, Parallel-group Study With Use of Budesonide/Formoterol "As-needed", or Terbutaline "As-needed" or Regular Use of Budesonide + Terbutaline "As-needed", in Patients With Mild Intermittent Asthma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Jan 2014
Price :
$35
*
At a glance
- Drugs Budesonide/formoterol (Primary) ; Budesonide; Terbutaline
- Indications Exercise-induced asthma
- Focus Therapeutic Use
- Acronyms MIA
- Sponsors AstraZeneca
- 28 Sep 2011 Results presented at the 21st Annual Congress of the European Respiratory Society.
- 18 Nov 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 09 Oct 2009 New trial record